AMYOTROPHIC LATERAL SCLEROSIS (ALS), A PARADIGM OF THE COMPLEXITY OF NEURODEGENERATIVE DISEASES WITHOUT EFFECTIVE THERAPIES, IS TODAY THE PLAN OF COMPARISON ON THE STRATEGIC CAPACITY THAT REGIONAL HEALTH AND RESEARCH SYSTEMS ARE ABLE TO EXPRESS INTERNATIONALLY. ON THIS PLAN INTERSLA INTENDS TO COMPETERE.INTERSLA Ê A PROJECT THAT COMBINES A CONSOLIDATED NETWORK OF PUBLIC AND PRIVATE EXCELLENCE IN BASIC NEUROSCIENCE, CLINICAL AND INDUSTRIAL WITH TWENTY YEARS EXPERIENCE ON SLA AND CONCRETE THE CONCEPT OF LIVING-LAB WITHIN A NEW DIMENSION OF RESPONSIBLE RESEARCH AND INNOVATION, WHOSE IMPACT WILL PROJECT THE LOMBARDY REGION EVEN MORE SOLIDLY IN THE INTERNATIONAL COMPETITION IN THE AREA OF NEURODEGENERATIVE DISEASES.THE NATURE OF THE CONSORTIUM AND THE STRUCTURE OF THE PROJECT ARE AIMED AT FOUR STRATEGIC OBJECTIVES: FACILITATING RELATIONS BETWEEN BUSINESSES, RESEARCH CENTRES AND PATIENTS, PUTTING EXCELLENCE INTO THE SYSTEM, TECHNOLOGY TRANSFER